All Formulation & Delivery Content

Bringing you the latest research in drug formulation, drug delivery, bioanalysis and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Insight Article
Explore the groundbreaking advancements in inhaled drug delivery, a transformative approach that promises enhanced efficacy and patient convenience
Edited by Guillaume Alonso |
06 December 2023
Inhaled Drug Delivery
Industry Spotlight
Inhalation products provide a patient-centric approach to delivering therapeutics directly to the lungs: with an estimated 800 million people suffering from chronic respiratory diseases worldwide, major potential for greater utility exists.
Edited by Ben Norris |
01 September 2023
Inhaled Drug Delivery
Industry Spotlight
One of the pioneers of inhaled therapies, David Jack discovered countless drugs to treat asthma and similar conditions.
Edited by Tom Cohen |
18 May 2023
Inhaled Drug Delivery
Insight Article
Inhaled biologics are being evaluated as an alternative to injections for treating rare and serious diseases. Experts touch on several challenges including making stable and safe formulations of inhaled biologics.
Edited by Tom Cohen |
13 April 2023
Inhaled Drug Delivery
Discussion Group Report
Our Inhaled Therapeutics discussion group brought together key experts in the field of dry powder formulation to discuss their research into both formulation and process.
Edited by Tom Cohen |
09 November 2022
Inhaled Drug Delivery
Insight Article
Our expert panel discuss the process of ensuring that inhalation devices are not burdensome to use.
Edited by Tom Cohen |
31 October 2022
Inhaled Drug Delivery
Commentary
When designing drug-delivery devices, the patient must be at the centre of the development process. NĂ©lio Drumond of Takeda Pharmaceuticals discusses how this patient-centric approach allows the design to maximise efficiency and efficacy.
17 October 2022
Inhaled Drug Delivery
Whitepaper
Recipharm offers inhalation and nasal product development services in compliance with regulatory guidelines from the ICH, EMA and FDA.
01 August 2022
Inhaled Drug Delivery
Commentary
Inhaled drugs are a viable means of targeting tobacco smoke-related diseases in the lungs: permeability is key to their successful delivery. This Commentary article explores the mechanisms by which drugs are delivered across cell membranes, as well as pertinent areas for present and future research.
30 June 2022
Inhaled Drug Delivery
Discussion Group Report
This month, the discussion group debated the advantages and disadvantages of different types of inhalers. One key area of interest was current-day challenges with aerosol delivery, which could be addressed through smart inhalers and other innovative new devices.
Edited by Oliver Picken |
17 March 2022
Inhaled Drug Delivery

Search by Keyword

Filter by Subject Area

Formulation & Delivery Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)